Gene therapy for cancer prodrug activation studies using recombinant adenoviral vector carrying herpes simplex virus thymidine kinase HSV tk gene and ganciclovir GCV

dc.contributor.guide	Mulherkar, Rita
dc.coverage.spatial
dc.creator.researcher	Srivastava, Deepika
dc.date.accessioned	2023-11-06T06:11:29Z
dc.date.available	2023-11-06T06:11:29Z
dc.date.awarded
dc.date.completed	2011
dc.date.registered
dc.description.abstract	newlineNo newline
dc.description.note
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent	114p
dc.identifier.uri	http://hdl.handle.net/10603/523334
dc.language	English
dc.publisher.institution	Applied Biology, Tata Memorial Centre
dc.publisher.place	Mumbai
dc.publisher.university	University of Mumbai
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Biology
dc.subject.keyword	Biology and Biochemistry
dc.subject.keyword	Ganciclovir
dc.subject.keyword	Gene Therapy
dc.subject.keyword	Life Sciences
dc.subject.keyword	Recombinant Adenoviral Vector
dc.subject.keyword	Thymidine Kinase
dc.subject.keyword	Trimeric Glycoprotein
dc.title	Gene therapy for cancer prodrug activation studies using recombinant adenoviral vector carrying herpes simplex virus thymidine kinase HSV tk gene and ganciclovir GCV
dc.title.alternative
dc.type.degree	Ph.D.